IRIS
TASSO, BRUNO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 8.615
AS - Asia 1.141
NA - Nord America 519
SA - Sud America 94
AF - Africa 25
OC - Oceania 1
Totale 10.395
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 8.428
SG - Singapore 494
US - Stati Uniti d'America 491
CN - Cina 334
VN - Vietnam 199
FR - Francia 64
BR - Brasile 52
HK - Hong Kong 37
FI - Finlandia 36
DE - Germania 28
AR - Argentina 21
JP - Giappone 18
MX - Messico 17
GB - Regno Unito 11
IQ - Iraq 10
ZA - Sudafrica 10
CA - Canada 8
BD - Bangladesh 7
CH - Svizzera 6
MA - Marocco 6
PH - Filippine 6
PK - Pakistan 6
RU - Federazione Russa 6
ID - Indonesia 5
IN - India 5
PL - Polonia 5
PY - Paraguay 5
IE - Irlanda 4
TR - Turchia 4
CO - Colombia 3
EC - Ecuador 3
NL - Olanda 3
SA - Arabia Saudita 3
SE - Svezia 3
SI - Slovenia 3
UY - Uruguay 3
VE - Venezuela 3
AL - Albania 2
CL - Cile 2
DZ - Algeria 2
ES - Italia 2
HR - Croazia 2
KE - Kenya 2
MD - Moldavia 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
BE - Belgio 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
KG - Kirghizistan 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
LU - Lussemburgo 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
SN - Senegal 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UA - Ucraina 1
Totale 10.395
Salva come PNG Salva come JPEG
Città #
Genova 4.298
Genoa 2.675
Rapallo 737
Vado Ligure 620
Singapore 250
San Jose 190
Ho Chi Minh City 63
Lauterbourg 59
Council Bluffs 56
Ashburn 50
Hanoi 46
Beijing 41
Helsinki 34
Hong Kong 34
New York 34
Bordighera 23
Frankfurt am Main 22
Santa Clara 20
Tokyo 18
Tianjin 17
Milan 10
Da Nang 9
Florence 9
Mexico City 9
São Paulo 8
Biên Hòa 7
Los Angeles 7
Guangzhou 6
Zurich 6
Chicago 5
Des Moines 5
Haiphong 5
Hangzhou 5
Turin 5
Warsaw 5
Baghdad 4
Buffalo 4
City of London 4
Dublin 4
Johannesburg 4
Orem 4
Phủ Lý 4
Amsterdam 3
Casablanca 3
Ljubljana 3
London 3
Long Xuyen 3
Montevideo 3
Ninh Bình 3
Phủ Từ Sơn 3
Wuppertal 3
Asunción 2
Bari 2
Belgrade 2
Belo Horizonte 2
Bologna 2
Borghetto di Vara 2
Camerino 2
Cardiff 2
Catania 2
Clorinda 2
Dhaka 2
Erbil 2
Hải Dương 2
Istanbul 2
José Bonifácio 2
Kenitra 2
Lappeenranta 2
Manaus 2
Nairobi 2
Nam Định 2
Nuremberg 2
Paris 2
Phuket 2
Quảng Ngãi 2
Quận Bình Thạnh 2
Quận Hai 2
Recife 2
Resistencia 2
Rio de Janeiro 2
Riyadh 2
Rosario 2
Salt Lake City 2
San Jose del Monte 2
San Lazzaro di Savena 2
St Louis 2
Stockholm 2
Tashkent 2
Thái Nguyên 2
Torreón 2
Tân Tiến 2
Vancouver 2
Villeurbanne 2
Vinh 2
Zagreb 2
Zhenjiang 2
Ân Thi 2
Acalanes Ridge 1
Acará 1
Addis Ababa 1
Totale 9.538
Salva come PNG Salva come JPEG
Nome #
Antiviral activity of benzimidazole derivatives. III. Novel anti-CVB-5, anti-RSV and anti-Sb-1 agents 243
Antiviral activity of benzimidazole derivatives. II Antiviral activity of 2-phenylbenzimidazole derivatives. 234
Synthesis and biological evaluation of novel thiazole- VX-809 hybrid derivatives as F508del correctors by QSAR-based filtering tools 231
Antiviral and cytotoxic activities of aminoarylazo compounds and aryltriazene derivatives 216
Acridine derivatives as anti-BVDV agents 207
Benzimidazole derivatives endowed with potent antileishmanial activity 207
Quinolizidinyl-benzimidazoles as platelet-antiaggregating agents 203
Antiviral activity of benzotriazole derivatives. 5-[4-(Benzotriazol-2-yl)phenoxy]-2,2-dimethylpentanoic acids potently and selectively inhibit Coxsackie Virus B5 202
Celecoxib Inhibits Prion Protein 90-231-Mediated Pro-inflammatory Responses in Microglial Cells 197
Benzimidazole-based derivatives as privileged scaffold developed for the treatment of the RSV infection: a computational study exploring the potency and cytotoxicity profiles 189
Vitamin E-coated filter decreases levels of free 4-hydroxyl-2-nonenal during haemodialysis sessions 185
Differential modulation of SIRT6 deacetylase and deacylase activities by lysine-based small molecules 183
Cytisine derivatives as ligands for neuronal nicotine receptors and with various pharmacological activities 182
CC4, a dimer of cytisine, is a selective partial agonist at α4β2/α6β2 nAChR with improved selectivity for tobacco smoking cessation 179
Novel celecoxib analogues inhibit glial production of prostaglandinE2, nitric oxide, and oxygen radicals reverting the neuroinflammatoryresponses induced by misfolded prion protein fragment 90-231 or lipopolysaccharide 178
Antitubercular activity of quinolizidinyl/pyrrolizidinylalkyliminophenazines 176
(+)-Laburnamine, a natural selective ligand and partial agonist for the α4β2 nicotinic receptor subtype 172
Host dihydrofolate reductase (DHFR)-directed cycloguanil analogues endowed with activity against influenza virus and respiratory syncytial virus 172
The Influence of the Nitrogen Substitution in Three Cytisine Derivatives as Ligands for the Neuronal nAChRs: A Structural and Theoretical Study 170
Organometallic compounds in oncology: implications of novel organotins as antitumor agents 166
Multitarget Therapeutic Leads for Alzheimer’s Disease: Quinolizidinyl Derivatives of Bi- and Tricyclic Systems as Dual Inhibitors of Cholinesterases and beta-Amyloid (Abeta) Aggregation 166
Novel Quinolizidinyl Derivatives as Antiarrhythmic Agents 166
Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation 161
Efficacy of novel acridine derivatives in the inhibition of hPrP90-231 prion protein fragment toxicity 156
Antitubercular and antiprotozoal activities of quinolizidinyl/pyrrolizidinylalkyliminophenazines 155
Computational approaches for the design and chemical synthesis of novel F508del correctors in the treatment of cystic fibrosis 154
Celecoxib, a COX-2 inhibitor, blocks microglial activation induced by a neurotoxic conformer of hPrP90-231 153
New arylsparteine derivatives as positive inotropic drugs 153
N-Homolupinanoyl and N-(ω-lupinylthio)alkanoyl derivatives of some tricyclic systems as ligands for muscarinic M1 and M2 receptor subtypes 152
Discovery of novel VX-809 hybrid derivatives as F508del-CFTR correctors by molecular modeling, chemical synthesis and biological assays 152
In vitro cytotoxic activity of tri-n-butyltin(IV)lupinylsulfide hydrogen fumarate (IST-FS 35) and preliminary antitumor activity in vivo 151
Epimerization of lupinine to epilupinine and vice versa. Reexamination of the structures of lupinal and epilupinal 151
New coumarin hybrids with antiproliferative activity against a neuroblastoma cell line 148
Synthesis and pharmacological evaluation of some thiolupinine derivatives 145
On the self-condensation of aminoguanidine leading to 1,1,4,10,10-pentaamino-2,3,5,6,8,9-hexaazadeca-1,3,5,7,9-pentaene (Structure elucidation through X-ray powder diffraction) 144
Synthesis, binding, and modeling studies of new cytisine derivatives as ligands for neuronal nicotinic acetylcholine receptor subtypes 142
Synthesis and structure-activity relationship of aminoarylthiazole derivatives as potential potentiators of the chloride transport defect in cystic fibrosis 140
Short exposure to high concentrations of malondialdehyde does not mimic physiological conditions 139
Quinolizidinyl derivatives of bi- and tricyclic systems as potent inhibitors of acetyl- and butyrylcholinesterase with potential in Alzheimer's disease 135
Quinolizidinyl derivatives of 5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one as ligands for muscarinic receptors 133
Cap 10 - Recettori adrenergici e farmaci attivi sulla neurotrasmissione adrenergica 132
Cap 16 - Anestetici generali ed anestetici locali 127
Multitarget Biological Profiling of New Naphthoquinone and Anthraquinone-Based Derivatives for the Treatment of Alzheimer's Disease 127
Discovery of Novel Thiazole-Based SIRT2 Inhibitors as Anticancer Agents: Molecular Modeling, Chemical Synthesis and Biological Assays 126
Exploring the effectiveness of novel benzimidazoles as CB2 ligands: synthesis, biological evaluation, molecular docking studies and ADMET prediction 123
Journey on VX-809-Based Hybrid Derivatives towards Drug-like F508del-CFTR Correctors: From Molecular Modeling to Chemical Synthesis and Biological Assays 120
Journey on naphthoquinone and anthraquinone derivatives: New insights in alzheimer’s disease 117
Btk inhibitors: a medicinal chemistry and drug delivery perspective 117
Targeting the p53/xCT/GSH Axis with PRIMA-1Met Combined with Sulfasalazine Shows Therapeutic Potential in Chronic Lymphocytic Leukemia 112
Molecular Docking and QSAR Studies as Computational Tools Exploring the Rescue Ability of F508del CFTR Correctors 110
Synthesis and biological investigation of 2-(tetrahydropyran-2'-yl) and 2-(tetrahydrofuran-2'-yl)-benzimidazoles 109
Quinolizidinyl derivatives of iminodibenzyl and phenothiazine as multidrug resistance modulators in ovarian cancer cells 109
Novel organotins as antitumor agents 107
Cap 11 - Recettori della serotonina e farmaci attivi sulla neurotrasmissione serotoninergica 106
Synthesis and antiplasmodial activity of novel chloroquine analogues with bulky basic side chains 101
Quinolizidinyl derivatives of bi- and tricyclic systems as AChE/BchE and beta-amyloid aggregation inhibitors, 100
Cap. 9 - Farmaci attivi sulla neurotrasmissione colinergica 99
Investigations of Antioxidant and Anti-Cancer Activities of 5-Aminopyrazole Derivatives 94
PTC596-Induced BMI-1 Inhibition Fights Neuroblastoma Multidrug Resistance by Inducing Ferroptosis 92
Microbiological Screening of 5-Functionalized Pyrazoles for the Future Development of Optimized Pyrazole-Based Delivery Systems 88
Quinone-based derivatives: a new class of multi-target agents against Alzheimer’s disease 87
Primary anti-proliferative activity evaluation of 1-(quinolizidin-1'-yl)methyl- and 1-([Formula: see text]-tert-amino)alkyl-substituted 2-phenyl-, 2-benzyl- and 2-[(benzotriazol-1/2-yl)methyl]benzimidazoles on human cancer cell lines. 85
BMI-1 inhibition fights cancer chemoresistance by altering redox homeostasis and inducing lipid peroxidation 85
New pyrazolyl thioureas active against the Staphylococcus genus 82
Synthesis and prelimary docking studies of new colchicine-benzotriazole hybrid compounds 80
Glutathione in cancer progression and chemoresistance: an update 79
Quinolizidine-derived lucanthone and amitriptyline analogues endowed with potent antileishmanial activity 72
Indole Antitumor Agents in Nanotechnology Formulations: An Overview 71
Further quinolizidine derivatives as antiarrhythmic agents-3 70
Design and synthesis of new coumarin hybrids with antiproliferative activity against neuroblastoma cells 69
New Class of Benzodiazepinone Derivatives as Pro-Death Agents Targeting BIR Domains in Cancer Cells 69
The Development of FAK Inhibitors: A Five-Year Update 68
Whey proteins inhibit food intake and tend to improve oxidative balance in obese zucker rats 67
New naphtho- and anthraquinone derivatives as Cholinesterase inhibitors for the treatment of Alzheimer's disease 61
Structure-guided combination of novel CFTR correctors to improve the function of F508del-CFTR in airway epithelial cells 58
New insights on Fak and Fak inhibitors 55
NEW HYBRID COUMARIN–SUBSTITUTED ALICYCLIC AMINES AS POTENTIAL MULTITARGET DIRECT LIGANDS FOR THE TREATMENT OF ALZHEIMER’S DISEASE 52
Hybrid molecules phenothiazine/cinnamic derivatives as MTDL and their biological evaluation 48
Nanotechnology for Pediatric Retinoblastoma Therapy 44
null 38
Nanotechnology of tyrosine kinase inhibitors in cancer therapy: A perspective 35
SYNTHESIS AND STRUCTURE–ACTIVITY RELATIONSHIP OF COUMARIN HYBRIDS WITH ANTIPROLIFERATIVE PROPERTIES AGAINST A MULTIDRUG-RESISTANT NEUROBLASTOMA CELL LINE 35
The Development of BTK Inhibitors: A Five-Year Update 30
null 28
Design and Synthesis of New Coumarin Hybrids Active Against Drug-Sensitive and Drug-Resistant Neuroblastoma Cells 27
New hybrids coumarins– substituted alicyclic amines as potential multi target direct ligands for the treatment of Alzheimer’s disease 26
Totale 10.625
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.291
article - articoli 28.553
book - libri 0
conference - conferenze 3.360
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.378
Totale 66.582
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021165 0 0 0 0 0 0 0 0 0 62 63 40
2021/2022866 38 48 79 83 31 46 47 190 46 69 48 141
2022/2023860 74 55 15 91 155 151 4 57 140 5 101 12
2023/2024512 21 86 19 82 27 70 20 46 19 17 55 50
2024/20251.716 41 106 58 96 210 180 195 310 66 76 193 185
2025/20263.096 395 86 324 340 461 224 484 200 255 327 0 0
Totale 10.625